Perspective on Roseroot (Rhodiola rosea) Studies

 

 Permissions and Reprints

Abstract

Rhodiola rosea (roseroot) extract is a commercially successful product, primarily used to reduce the effect of fatigue on physical and mental performance. In this perspective we present our investigation of the most recent studies performed on human subjects. With a focus on the statistical methods we found considerable shortcomings in all but one of the studies that claim significant improvement from roseroot extract. Overall, the study designs have not been well explained. Experimental results have been confused and appear to be in some cases incorrect. Some of the conclusions are based on selected results and contradicting data have not been adequately taken into account. We point to other studies of higher quality performed on roseroot, several that found no significant effect and one that did. We conclude that the currently available evidence for the claimed effects is insufficient and that the effect of Rhodiola rosea is in need of further investigation before therapeutic claims can be made.

References

• 1 Spasov A A, Wikman G, Mandrikov V B, Mironova I A, Neumoin V V. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR‐5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.  Phytomedicine. 2000;  7 85-89
  CrossrefPubMedGoogle Scholar
• 2 Spasov A A, Mandrikov V B, Mironova I A. Effect of Rhodaxon preparation on the psychophysiological and physical adaptations of students to learning load.  Eksp Klin Pharmacol. 2000;  63 76-78
  PubMedGoogle Scholar
• 3 Darbinyan V, Kteyan A, Panossian A, Gabriellian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue – a double blind cross-over study of a standardized extract SHR‐5 with repeated low-dose regimen on the mental performance of healthy physicians during night duty.  Phytomedicine. 2000;  7 365-371
  CrossrefPubMedGoogle Scholar
• 4 Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR‐5 in the treatment of mild to moderate depression.  Nord J Psychiatry. 2007;  61 343-348
  CrossrefPubMedGoogle Scholar
• 5 Walsh T. Placebo response in studies of major depression: variable, substantial, and growing.  JAMA. 2002;  287 1840-1847
  CrossrefPubMedGoogle Scholar
• 6 Shevtsov V A, Zholus B I, Shervarly V I, Vol'skij V B, Korovin Y P, Khristich M P, Roslyakova N A, Wikman G. A randomized trial of two different doses of a SHR‐5 Rhodiola rosea extract versus placebo and control of capacity for mental work.  Phytomedicine. 2003;  10 95-105
  CrossrefPubMedGoogle Scholar
• 7 Fintelmann V, Gruenwald J. Efficacy and tolerability of Rhodiola rosea extract in adults with physical and cognitive deficiencies.  Adv Ther. 2007;  24 929-939
  CrossrefPubMedGoogle Scholar
• 8 Bystritsky A, Kerwin L, Feusner J D. A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD).  J Altern Complement Med. 2008;  14 175-180
  CrossrefPubMedGoogle Scholar
• 9 Olsson M G, von Schéele B, Panossian A G. A randomized, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR‐5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.  Planta Med. 2009;  75 105-112
  Article in Thieme ConnectPubMedGoogle Scholar
• 10 DeBock K, Eijnde B O, Ramaekers M, Hespel P. Acute Rhodiola rosea intake can improve endurance exercise performance.  Int J Sport Nutr Exerc Metab. 2004;  14 298-307
  CrossrefPubMedGoogle Scholar
• 11 Walker T B, Altobelli S A, Caprihan A, Robergs R A. Failure of Rhodiola rosea to alter skeletal muscle phosphate kinetics in trained men.  Metabolism. 2007;  56 1111-1117
  CrossrefPubMedGoogle Scholar
• 12 Colson S N, Wyatt F B, Johnston D L, Autrey L D, Fitzgerald Y L, Earnest C P. Cordyceps sinensis- and Rhodiola rosea-based supplementation in male cyclist and its effect on muscle tissue oxygen saturation.  J Strength Res. 2005;  19 358-363
  PubMedGoogle Scholar
• 13 Earnest C P, Morss G M, Wyatt F, Jordan A N, Colson S, Church T S, Fitzgerald Y, Autery L, Jurca R, Lucia A. Effects of a commercial herbal-based formula on exercise performance in cyclists.  Med Sci Sports Exerc. 2004;  36 504-509
  CrossrefPubMedGoogle Scholar
• 14 Walker T B, Robergs R A. Does Rhodiola rosea possess ergogenic properties?.  Int J Sport Nutr Exerc Metab. 2006;  16 305-315
  PubMedGoogle Scholar
• 15 Roland P D, Amundstuen L. Roseroot, statements and documentation.  Tidsskr Nor Lægeforen. 2007;  127 882-883
  PubMedGoogle Scholar

Prof. Dan Larhammar

Department of Neuroscience, Unit of Pharmacology
Uppsala University

Box 593

75124 Uppsala

Sweden

Phone: + 46 1 84 71 41 73

Fax: + 46 18 51 15 40

Email: Dan.Larhammar@neuro.uu.se